Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Vaccination
69%
HPV16
68%
Human Papillomavirus
67%
Vaccine Effectiveness
36%
Papillomavirus Infections
27%
High-risk Human Papillomavirus (HR-HPV)
25%
Cervical Cancer
25%
Type-specific
24%
Cross-protection
23%
Cervical Cancer Screening
19%
Human Papillomavirus Types
19%
Incremental Cost-effectiveness Ratio
17%
Vaccination Program
17%
HPV Vaccine
16%
Unvaccinated
16%
Medicine and Dentistry
Wart Virus
100%
Human Papillomavirus Type 16
45%
Infection
30%
Papillomavirus Infection
21%
Cervical Cancer
20%
Prevalence
19%
Health Care Cost
19%
Wart Virus Vaccine
19%
Malignant Neoplasm
16%
Microflora
15%
Cytotechnology
15%
Men Who Have Sex with Men
15%
Herd
13%
Randomized Controlled Trial
13%
Cervical Cancer Prevention
13%